Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

10.92USD
21 Sep 2017
Change (% chg)

$0.08 (+0.74%)
Prev Close
$10.84
Open
$10.85
Day's High
$10.93
Day's Low
$10.80
Volume
99,813
Avg. Vol
103,413
52-wk High
$11.55
52-wk Low
$6.92

Chart for

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $860.57
Shares Outstanding(Mil.): 79.39
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 29.78 16.33
EPS (TTM): -- -- --
ROI: -- 6.58 14.66
ROE: -- 10.40 13.99

BRIEF-Neogenomics reports on impact from hurricane Irma

* Hurricane Irma had minimal impacts to Fort Myers, FL facility​

Sep 11 2017

BRIEF-Neogenomics announces expansion of its immuno-oncology profiling test menu

* Announced an expansion of its immuno-oncology profiling test menu

Jun 02 2017

BRIEF-NeoGenomics sees Q2 2017 adjusted earnings per share $0.03-$0.04

* Neogenomics reports 15% volume growth and 10% reduction in average cost per test in the first quarter of 2017

Apr 26 2017

BRIEF-Neogenomics names new Vice President

* Neogenomics appoints Bill Bonello as vice president, treasurer, and director of corporate development Source text for Eikon: Further company coverage:

Apr 20 2017

Earnings vs. Estimates